Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Myovant Sciences Ltd. (MYOV)
Sector: Healthcare; Industry: Biotechnology

Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health and endocrine diseases. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. The company was founded in 2016 and is based in London, the United Kingdom.

MYOV Symbol Info by TradingView

Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-09-23 Sumitomo Chemical Co., Ltd. 10%-Owner Buy 138,796 $22.39 $3,108,226 No
2021-09-21 Sumitomo Chemical Co., Ltd. 10%-Owner Buy 81,273 $22.30 $1,812,120 No
2021-09-17 Sumitomo Chemical Co., Ltd. 10%-Owner Buy 87,913 $22.20 $1,951,656 No
2021-09-09 Curran Terrie Director Sell 4,850 $25.58 $124,063 Yes
2021-08-30 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 22,978 $23.93 $549,931 Yes
2021-08-25 Sumitomo Chemical Co., Ltd. 10%-Owner Buy 63,008 $22.40 $1,411,427 No
2021-07-07 KARBE FRANK Principal Fin'l & Accounting Sell 3,232 $21.75 $70,296 No
2021-05-28 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 3,083 $24.00 $73,992 Yes
2021-05-26 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 12,700 $24.23 $307,721 Yes
2021-04-06 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 8,114 $18.63 $151,164 No
2021-04-06 Lang Matthew General Counsel & Corp. Secy. Sell 10,862 $18.62 $202,250 No
2021-04-06 KARBE FRANK Principal Fin'l & Accounting Sell 11,080 $18.63 $206,420 No
2021-03-19 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 7,000 $24.17 $169,190 Yes
2021-03-15 Lang Matthew General Counsel & Corp. Secy. Sell 30,000 $25.07 $752,013 Yes
2021-03-01 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 1,513 $22.55 $34,118 No
2021-02-16 KARBE FRANK Principal Fin'l & Accounting Sell 750 $21.40 $16,050 Yes
2021-01-28 KARBE FRANK Principal Fin'l & Accounting Sell 300 $24.00 $7,200 Yes
2021-01-15 KARBE FRANK Principal Fin'l & Accounting Sell 750 $21.50 $16,125 Yes
2020-12-28 KARBE FRANK Principal Fin'l & Accounting Sell 11,800 $30.00 $354,000 Yes
2020-12-18 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 2,000 $26.00 $52,000 Yes
2020-12-18 Lang Matthew General Counsel & Corp. Secy. Sell 10,000 $25.41 $254,054 Yes
2020-12-15 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 7,000 $23.92 $167,426 Yes
2020-12-15 KARBE FRANK Principal Fin'l & Accounting Sell 1,050 $24.15 $25,363 Yes
2020-12-10 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 10,000 $26.04 $260,362 Yes
2020-12-10 Lang Matthew General Counsel & Corp. Secy. Sell 20,000 $25.19 $503,832 Yes
2020-11-30 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 1,978 $23.65 $46,780 No
2020-11-30 KARBE FRANK Principal Fin'l & Accounting Sell 1,500 $24.00 $36,000 Yes
2020-11-17 KARBE FRANK Principal Fin'l & Accounting Sell 750 $20.00 $15,000 Yes
2020-11-17 Arjona Ferreira Juan Camilo Chief Medical Officer Sell 7,000 $20.00 $140,000 Yes
2020-11-13 KARBE FRANK Principal Fin'l & Accounting Sell 750 $20.00 $15,000 Yes

Insider Smart

MGM Resorts International (MGM) - If we were to pick one of the easy trade from the crash, it has to be MGM, checkout the impressive insider buying after crash. Do you really need more confidence to pull the trigger? That's the mental edge you need to work against fear.

Insider Smart

Ovintiv Inc (OVV) - Insiders of OVV have been HEAVILY accumulating shares in March with a sub-$3 cost. And the stock is now $11. An awesome 400% gain can't be missed if you found it was heavily accumulated earlier.